Oxlumo
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Oxlumo, covering 2020-11-23 to 2025-10-13. Get the full timeline:
Most recent: EMA Authorised: Oxlumo (Lumasiran sodium) — Alnylam Netherlands B.V.
6 regulatory and trial events tracked for Oxlumo, covering 2020-11-23 to 2025-10-13. Get the full timeline:
Most recent: EMA Authorised: Oxlumo (Lumasiran sodium) — Alnylam Netherlands B.V.